SOLOREL
DEAD

Serial Number

77658985

Owner

AEterna Zentaris GmbH

Attorney

Jeffrey H. Kaufman

Filing Date

Jan 29, 2009

Add to watchlist:

No watchlists yet
View on USPTO

SOLOREL Trademark

Serial Number: 77658985 • Registration: 3724729

SOLOREL is a trademark filed by AEterna Zentaris GmbH on January 29, 2009. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

AEterna Zentaris GmbH (29 trademarks)

Weismüllerstrasse 50

Entity Type: 16

Trademark Details

Filing Date

January 29, 2009

Registration Date

December 15, 2009

Published for Opposition

June 30, 2009

Cancellation Date

July 22, 2016

Goods & Services

Pharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of age-related diseases, pharmaceutical preparation used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myoma, pharmaceutical preparations used for the treatment of non-malignant tumors, pharmaceutical preparation used for the treatment for benign prostatic hyperplasia (BPH), pharmaceutical preparations used as a tubulin inhibitor, pharmaceutical preparations based on LHRH antagonists platform for the treatment of cancer, cancer in combination with administered radiosensitizing, urological diseases, hormonal disorders, hormonal and tumor disorders, endocrine diseases,carcinoid tumors, age-related diseases, endometriosis, uterine myoma, non-malignant tumors and benign prostatic hyperplasia; pharmaceutical preparations used to induce apoptosis

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 22, 2016 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 11, 2015 TCCA
REGISTERED-PRINCIPAL REGISTER
Dec 15, 2009 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Nov 5, 2009 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 5, 2009 AITU
NOTICE OF ALLOWANCE CANCELLED
Oct 30, 2009 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Oct 30, 2009 D1BR
NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 22, 2009 NOAM
PUBLISHED FOR OPPOSITION
Jun 30, 2009 PUBO
NOTICE OF PUBLICATION
Jun 10, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 22, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
May 21, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 21, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
May 21, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 21, 2009 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 13, 2009 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 8, 2009 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 28, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2009 CNSA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Apr 22, 2009 GPRN
PRIORITY ACTION E-MAILED
Apr 22, 2009 GPRA
PRIORITY ACTION WRITTEN
Apr 22, 2009 CPRA
ASSIGNED TO EXAMINER
Apr 15, 2009 DOCK
AMENDMENT FROM APPLICANT ENTERED
Mar 19, 2009 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2009 CRFA
PAPER RECEIVED
Mar 18, 2009 MAIL
AMENDMENT FROM APPLICANT ENTERED
Feb 6, 2009 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2009 CRFA
ASSIGNED TO LIE
Feb 5, 2009 ALIE
PAPER RECEIVED
Feb 3, 2009 MAIL
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 2, 2009 NWOS
NEW APPLICATION ENTERED
Feb 2, 2009 NWAP